Tymer

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tymer

Property Description
Active ingredient Gatifloxacin (sesquihydrate)
Form Ophthalmic Solution (Eye Drops)
Pharmacological class Fourth-Generation Fluoroquinolone Antibiotic
Common use Elimination of susceptible bacterial eye pathogens
Origin Synthetic

Tymer: Classification and Composition

Tymer is a prescription-only (Rx) pharmaceutical preparation whose active ingredient is Gatifloxacin, typically formulated as the sesquihydrate compound. The drug is definitively classified as an antibiotic belonging to the fourth-generation fluoroquinolone subclass within the broader quinolone antimicrobial pharmacological class. This classification confirms its identity as a powerful, laboratory-developed compound designed for potent antimicrobial action. The development of this synthetic agent is directed toward improving the spectrum and potency against bacterial resistance.

The Form and General Use of Gatifloxacin Ophthalmic Solution

Tymer is exclusively manufactured as an ophthalmic solution, widely known as eye drops, intended strictly for topical ophthalmic route of administration. This liquid dosage form is an aqueous solution formulated to deliver the Gatifloxacin directly to the eye's surface. A key differentiating factor for this formulation is its intended use for pediatric populations, as it is approved for patients as young as one year old. The overarching therapeutic purpose of this preparation is the elimination of susceptible bacteria responsible for ocular infection treatment. Fluoroquinolone eye drops serve as an option for treating localized external eye infections.

How Gatifloxacin Works to Eliminate Bacteria (High-Level Purpose)

The fundamental action of the medicine is bactericidal, meaning it is designed to actively and definitively kill bacteria rather than merely inhibiting their growth. This powerful antimicrobial effect is achieved by disrupting the core reproductive and maintenance functions of the bacterial cell. This mechanism provides the essential ability to quickly eliminate the source of infection, making the medicine a necessary tool for managing conditions caused by susceptible strains of surface-dwelling bacteria, such as those that cause common bacterial conjunctivitis.

What side effects are possible with Tymer?

Possible side effects and safety information

The official safety profile for Gatifloxacin ophthalmic solution (Tymer) is structured around adverse reactions reported during clinical studies and post-marketing surveillance, as documented in regulatory sources such as the FDA and NIH.

Documented Adverse Reactions

The most frequently reported effects (Common, 5%-mathbf10% incidence) are localized, primarily involving the Ophthalmic System. These include conjunctival irritation, keratitis (corneal inflammation), increased lacrimation, and papillary conjunctivitis. Less common reactions (1%-mathbf4% incidence) include eye pain, eyelid edema, dry eye, red eye, headache, and taste disturbance (dysgeusia)

.

System-Organ Class Common Adverse Reactions
Ophthalmic Disorders Conjunctival irritation, keratitis, increased lacrimation
Nervous System Disorders Headache
Gastrointestinal Disorders Dysgeusia (Taste disturbance)

Serious Safety Considerations

The official labeling notes the potential for Serious Hypersensitivity Reactions, including anaphylactic reactions, angioedema, and dyspnea, which can occur even following a single dose. Rare cases of Stevens-Johnson Syndrome have been associated with topical ophthalmic gatifloxacin use.

Safety-Related Restrictions and Constraints

The medication is contraindicated in patients with a history of hypersensitivity to Gatifloxacin or other quinolones. The risk of superinfection (overgrowth of non-susceptible organisms) is associated with prolonged use. Safety and effectiveness are established for pediatric patients as young as one year of age, as defined by regulatory documents.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Gatifloxacin ophthalmic solution is constrained by the drug's formulation for topical use, resulting in low systemic absorption. The official profile primarily details required actions for misuse rather than a severe systemic symptom cluster.


Documented Overdose Scenarios and Manifestations

Scenario Official Regulatory Statement Practical Implication
Accidental Ingestion The likelihood of acute systemic toxicity is considered remote. Management is symptomatic and supportive.
Excessive Topical Use No specific systemic symptoms are documented for topical overdose. Local irritation is the primary concern.
Misuse (Injection) Severe local damage, such as Corneal Endothelial Cell Injury, is a risk if improperly introduced into the anterior chamber. Strict adherence to topical use is required.

Immediate Actions Mandated by Regulators

The following actions are explicitly required in the event of misuse, as stated in official labeling:

  • Accidental Swallowing: Contact a healthcare professional or poison control centre immediately. This action is mandatory even if no symptoms are present.
  • Topical Over-Application: If too many drops are accidentally instilled in the eye, the solution may be flushed from the eye(s) with warm water.

No specific antidote for Gatifloxacin ophthalmic solution overdose is described or required in the regulatory information. Seeking emergency medical help is also required at the first sign of a serious allergic reaction, such as swelling of the face or difficulty breathing.

Therapeutic Uses of Tymer

Gatifloxacin ophthalmic solution is commonly used to treat bacterial conjunctivitis. This therapeutic approach is applied across conditions presenting with localized discomfort and is relevant when short-term symptomatic assistance is needed for patients, including children one year of age and older.

The medication helps address symptom clusters related to inflammatory or irritative states, notably pronounced eye redness, swelling, and the presence of mucopurulent discharge. In these acute episodes, the primary benefit is commonly used to help with the elimination of the bacterial cause, which supports the patient during difficult episodes by easing distress.

“The therapeutic action contributes to improved comfort during periods of heightened symptoms.”

In addition to bacterial conjunctivitis, its anti-bacterial scope is considered relevant for the management of more significant infections like bacterial keratitis and related corneal infections. In these scenarios, the application is often used in settings where additional management of discomfort is required and is applied in addressing symptomatic discomfort.

Quick Fact: Relief for Ocular Secretion and Inflammation

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Tymer (Gatifloxacin Ophthalmic Solution)

Tymer's eligibility is strictly defined by regulatory labeling concerning hypersensitivity, age, and reproductive status.

Classification Population/Condition Eligibility Status
Absolute Contraindication History of hypersensitivity to Gatifloxacin, other quinolones, or any component of the solution. Must not use
Age Group Adults and Pediatric patients aged one year and older. Use Established
Age Group Restriction Infants below one year of age. Use Not Established
Physiological Status Pregnant women. Conditional Use (if benefit outweighs risk)
Physiological Status Nursing women (Lactation). Use with Caution

Use is contraindicated for any individual with a history of allergic reaction to the active ingredient, to other antibiotics in the quinolone class, or to any inactive component in the formulation. The medicine is permitted for use in adults and in children who are one year of age or older, but safety and effectiveness have not been established in infants below this minimum age threshold. For pregnant and nursing women, official documents recommend conditional use or caution due to limited human data.

What should I know about interactions with other medicines?

Tymer Interactions with Other Medicines and Products

The interaction profile for Tymer (Gatifloxacin ophthalmic solution) is primarily defined by its topical ophthalmic route of administration. This method results in low or undetectable systemic absorption of the active ingredient, Gatifloxacin, which significantly reduces the potential for systemic drug-drug interactions with oral or injectable medications, as acknowledged in official regulatory prescribing information.

Documented Interaction Patterns and Restrictions

Official regulatory documents state that specific drug interaction studies have not been conducted for the ophthalmic solution. Consequently, Tymer's label does not list any specific established metabolic, transporter-mediated, or exposure-altering interactions with other systemic medicines.

Interaction Type Status in Regulatory Labeling
Formal Contraindicated Combinations None documented (other than hypersensitivity).
Systemic Drug-Drug Interactions None established for the ophthalmic solution.
Food, Alcohol, or Supplement Interactions None documented.

Ophthalmic Co-administration

The primary constraint related to administration involves other eye preparations. The official prescribing information advises patients not to use other eye medications during treatment with Gatifloxacin ophthalmic solution unless they are specifically instructed to do so by a healthcare professional. This restriction is a procedural safeguard related to the co-administration of topical ophthalmic products.

Mechanism of Action

Disrupting Bacterial DNA Synthesis and Structure

The active ingredient of Tymer acts by targeting and inhibiting two vital bacterial enzymes: DNA Gyrase and Topoisomerase IV. This interaction is characterized as Topoisomerase Poisoning, which stabilizes the cleavable complex. This stabilization mechanism directly causes multiple double-stranded DNA breaks and prevents the proper re-ligation of bacterial DNA strands, thereby compromising the chromosome's structural integrity.

Blocking Bacterial Replication and Cell Division

The molecular damage results in the disruption of two essential physiological pathways. Inhibition of DNA Gyrase halts the necessary unwinding and supercoiling of DNA required for replication, while inhibition of Topoisomerase IV blocks the final step of chromosome separation required for cell division. This combined mechanistic block leads to irreversible cellular damage, consistent with a bactericidal (cell-killing) effect against susceptible bacteria.

Dosage and Administration Information

How Tymer Is Used: Administration Guidelines

Tymer (Gatifloxacin Ophthalmic Solution) is an antibiotic preparation used according to standardized instructions. The medicine is for topical ophthalmic use only (eye drops) and must not be administered by injection or through other routes.

Standard Dosage and Frequency

The standard unit of application is one drop (1 gtt) applied to the affected eye(s) during the period the patient is awake. The full course of treatment is typically 7 days and follows a stepped-down frequency pattern, where the drops are used more frequently at the start of treatment and less often toward the end of the course.

Regimen (for Bacterial Conjunctivitis) Concentration (0.3% and 0.5%) Application Frequency (While Awake)
Initial Phase (Days 1-2) Both 0.3% and 0.5% Every two hours, up to 8 times daily
Maintenance Phase (Days 3-7) Both 0.3% and 0.5% 2 to 4 times daily

Administration Requirements

To ensure proper use, the solution is applied while the patient is awake. The applicator tip must not contact the eye or any other surface to maintain the sterility of the solution.

Population-Specific Use

This medicine can be used in pediatric patients who are one year of age or older, using the same standard dosing regimen as adults. No special dose adjustments are generally required for older adults or in cases of renal or hepatic impairment due to the drug's minimal systemic absorption.

Recent Clinical Evidence

Research evidence / Overview of studies for Tymer

Evidence for Use in Acute Bacterial Conjunctivitis

This evidence primarily consists of Randomized Controlled Trials (RCTs), a research design that minimizes bias in the comparison of treatments, where patients with conditions such as bacterial conjunctivitis are randomly assigned to receive either the medicine or an inactive solution, known as a vehicle. These short-term RCTs, typically conducted over less than seven days, research examined two primary measurements: clinical success and microbiological cure.

Clinical success was evaluated by monitoring changes in objective signs, such as conjunctival redness and mucopurulent discharge, while microbiological cure measured changes related to the elimination of the original infecting bacteria. Findings described patterns observed in the studies where the Gatifloxacin ophthalmic solution group reported measurements of both symptom resolution and bacterial eradication that were different from the inactive vehicle group. These studies monitored differences related to bacterial status when Gatifloxacin was studied against other established antibiotic eye drops.


Evidence for Use in Other Ocular Infections

For other, often more significant, ocular infections, such as those that may involve the cornea (e.g., bacterial keratitis), the available research is structured differently. The evidence base primarily comprises in vitro laboratory studies and pharmacokinetic research. The laboratory research examined the effect of the active ingredient against various specific bacterial strains that cause these infections. The pharmacokinetic studies, meanwhile, examined the distribution of the active ingredient in the ocular tissues, such as the cornea and aqueous humor, following the application of the eye drops.


What is Still Uncertain About the Research for Tymer

While the evidence base for acute bacterial conjunctivitis is well-established through controlled trials, several areas of uncertainty remain. The typical follow-up durations were limited in the primary clinical trials, meaning the research provides context but not individual predictions about long-term or maintenance outcomes. Comparative evidence is lacking for many potential matchups against newer or less common antibiotic eye drops, limiting the research's insight into relative patterns of performance across all currently available options.

Key Studies & References Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers (ClinicalTrials.gov ID NCT00651586)

Frequently Asked Questions (FAQ)

Common questions about Tymer (FAQ)


Q: How quickly should I expect to feel the effects of Tymer?

Studies on Tymer (Gatifloxacin ophthalmic solution) for bacterial conjunctivitis measure success by monitoring objective signs of improvement. Clinical success is evaluated throughout the short-term course. Patients should continue treatment for the full prescribed duration, even if initial changes are noticed early.


Q: Does Tymer interact with common over-the-counter pain relievers?

Regulatory documents state that specific drug interaction studies have not been conducted for the ophthalmic (eye drop) solution. Because the medicine is applied directly to the eye, it has minimal systemic absorption. Therefore, the potential for systemic drug-drug interactions with oral medicines, such as over-the-counter pain relievers, is considered low.


Q: Are there any long-term side effects associated with taking Tymer?

Tymer is an antibiotic prescribed for a short course, typically seven days. The official product information warns that prolonged use of the eye drops is associated with a risk of superinfection. This risk involves the overgrowth of non-susceptible organisms, such as fungi.


Q: Is it normal to have mild headaches when first starting Tymer?

Headaches were reported in 1% to 4% of patients during clinical studies for Tymer. Official information does not specify the exact timing of when this reaction may start or how long it may last. Ophthalmic adverse reactions like eye irritation and keratitis (corneal inflammation) are reported more commonly.


Q: What happens if I forget to take my Tymer dose sometimes?

Regulatory patient information generally guides patients to use a missed dose as soon as it is remembered. However, specific instructions regarding skipping a dose to avoid extra administration should be followed per the product’s patient leaflet or the prescriber’s guidance.


Q: Can I take vitamins or supplements while on Tymer?

Official interaction studies for Tymer involving vitamins, supplements, food, or alcohol have not been conducted, and no established interactions are listed. Patients are generally guided to inform their healthcare professional about all products, including vitamins and supplements, being used, as a standard safety practice.


Q: Does Tymer affect fertility or family planning?

Since the eye drops have minimal systemic absorption, the risk to human fertility from topical ophthalmic use is not well-established but is presumed to be minimal. Oral studies in animals did not show an effect on fertility.


Q: Is there a generic version of Tymer available?

Yes, the active ingredient in Tymer, Gatifloxacin ophthalmic solution, is available as a generic drug. Generic versions contain the identical active ingredient and are subject to the same strict regulatory approval processes as the brand-name product.


Q: What research is currently being done on Tymer?

Beyond the established clinical trials for bacterial conjunctivitis, governmental databases like ClinicalTrials.gov list research involving Gatifloxacin ophthalmic solution. This includes studies examining its role in settings like pre-operative prophylaxis to help prevent infection before eye surgery.


Q: Are there any withdrawal symptoms when stopping Tymer?

Tymer is a short-course antibiotic typically used for seven days. The official labeling does not list any specific withdrawal symptoms upon the completion of the treatment course, nor is it classified as a drug associated with physical dependence.


Q: Why does the packaging say to take Tymer with food?

The official instructions for Tymer ophthalmic solution do not include any guidance to take the medicine with food. This medication is strictly for topical ophthalmic use (eye drops) and is not swallowed. Its application is independent of food consumption.


Q: Will Tymer show up on a standard drug test?

Official data show that Tymer, when used as eye drops, has very low or undetectable systemic absorption. Due to the minimal systemic absorption, the amount of the active ingredient in the bloodstream is typically low. This suggests a reduced likelihood of the drug being detected on standard systemic drug screening, though individual results can vary.


Q: Is it okay to drive or operate machinery after taking Tymer?

Reported adverse reactions include temporary blurred vision and reduced visual acuity. Because of these potential visual effects, caution is warranted when driving or operating machinery until the visual disturbance has fully resolved.


Q: Can I take herbal remedies while on Tymer?

Specific interaction studies with herbal remedies have not been conducted for the ophthalmic solution. Due to the low systemic absorption, the risk of systemic interaction is minimal. As a standard safety practice, patients are generally guided to inform their healthcare professional about all products, including herbal remedies and supplements, they are currently using.


Q: Is there any specific lab work needed while taking Tymer?

The official regulatory label for Gatifloxacin ophthalmic solution does not typically specify any routine blood tests or systemic laboratory monitoring for patients using the eye drops for its intended surface ocular infection treatment.


Q: Does Tymer interact with birth control pills?

Specific drug interaction studies have not been conducted with the ophthalmic solution. Given the very low systemic absorption of the eye drops, the potential for drug-drug interactions with oral medications like birth control pills is considered low.


Q: Are there different strengths of Tymer available?

Yes, Gatifloxacin ophthalmic solution has been marketed in different strengths, which typically include both 0.3% and 0.5% concentrations. Both strengths follow a similar administration schedule for bacterial conjunctivitis.


Q: What should I know about taking Tymer before surgery?

Gatifloxacin ophthalmic solution has been studied for use before certain eye surgeries, such as cataract surgery, to help reduce the risk of infection. Standard safety practice requires patients to inform their surgeon about all current medications, including eye drops, if they are scheduled for any surgical procedure.


Q: Does Tymer have any known cardiovascular risks?

The adverse reactions reported in clinical trials for the ophthalmic solution do not include cardiovascular events. The low systemic exposure suggests that significant systemic effects, including cardiovascular ones, are generally not anticipated.


Q: Is it safe to use Tymer if I am lactose intolerant?

The official regulatory description of the inactive ingredients for Gatifloxacin ophthalmic solution, which is an aqueous solution, does not typically list lactose as a component. For specific product concerns regarding inactive ingredients, patients are guided to check the label or speak with a pharmacist.


Q: Why do some people experience stomach upset with Tymer?

The adverse reaction list for Tymer does not specifically mention 'stomach upset.' However, the clinical trial data report 'dysgeusia,' or taste disturbance, as a common side effect (occurring in 1% to 10% of patients). This altered sense of taste may sometimes be misinterpreted as a gastrointestinal issue.


Q: Can I take Tymer on an empty stomach?

Tymer is an eye drop solution and is intended for application to the eye, not to be swallowed. Therefore, the administration of the medicine is entirely independent of whether or not you have food in your stomach.


Q: Does Tymer have any known issues with sun sensitivity?

The official regulatory label for the ophthalmic solution does not list photosensitivity or increased sun sensitivity as a reported side effect. Some patient information advises wearing sunglasses if the eyes experience temporary increased sensitivity to light.


Q: How soon after stopping Tymer is it fully out of my system?

Due to the minimal systemic absorption after topical use, the active ingredient is not present in the body in significant systemic amounts for a measurable period. It is considered to be rapidly eliminated from the site of action once the full course is completed.


Q: What should I do if a side effect of Tymer doesn't go away?

Official patient information and regulatory guidance indicate that a healthcare professional should be contacted if any side effects persist, worsen, or cause concern during the treatment course. Any signs of a serious allergic reaction require immediate medical help.


Q: Are the side effects of Tymer permanent?

The common adverse reactions reported in clinical trials for Tymer, such as eye irritation or headache, are generally localized and transient. The official regulatory labeling does not describe these effects as permanent.


Q: What is the average duration of treatment with Tymer?

According to the official prescribing information, the recommended full course of treatment for the indicated use (bacterial conjunctivitis) is typically seven days.

How should Tymer be stored and disposed of?

How to Store and Dispose of Tymer?

The storage and disposal of Tymer (Gatifloxacin Ophthalmic Solution) must strictly adhere to the conditions mandated by regulatory labeling to maintain product integrity and safety.

Official Storage Conditions

Requirement Official Instruction
Temperature Store at Controlled Room Temperature (mathbf20 C - 25 C / mathbf68 F - 77 F).
Protection Keep from freezing, and protect from excess heat, moisture, and direct light.
Container Keep the medication in the original container and ensure it is tightly closed.
Child Safety Keep this medication out of the sight and reach of children by using safety caps and secure storage.

Stability and Disposal Rules

Stability rules mandate that the solution must be discarded after the expiry date or after the specified in-use stability period following opening (typically 30 days or 4 weeks). For disposal, unused or expired medicine must not be thrown into household trash or wastewater; instead, the regulatory guidance is to consult a pharmacist or use an approved medication take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tymer found in:

A-Z Index: